TLPH Q4 2018 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$613,000-17.2% YoY

Gross Profit

-$3M-543.1% margin

Operating Income

-$11M-1790.7% margin

Net Income

-$13M-2048.6% margin

EPS (Diluted)

$-3.56

QoQ Revenue Growth

+62.6%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$121M

Total Liabilities

$116M

Stockholders' Equity

$4M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$613,000	$740,000	-17.2%
Gross Profit	-$3M	-$4M	+14.6%
Operating Income	-$11M	-$8M	-40.6%
Net Income	-$13M	-$10M	-27.0%